Christine Blank
Groups praise lawsuit against Walgreens, CVS
Pharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
FDA warns about contaminated drugs, dietary supplements
FDA warned consumers and health care professionals not to use a certain brand of drugs and dietary supplements that are contaminated.
DEA wants to slash opioid production
The Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
FDA approves novel leukemia, hepatitis C drugs
FDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.
Amputation risk possible with diabetes drugs, FDA warns
Based on new data from 2 large clinical trials, FDA is warning that these blockbuster type 2 diabetes medications can cause an increased risk of leg and foot amputations.
FDA expands cystic fibrosis treatment
FDA expanded the use of ivacaftor (Kalydeco, Vertex Pharmaceuticals) to treat cystic fibrosis.
New FDA lead ushers in new era
Scott Gottlieb, MD, was sworn in as the new FDA commissioner and ushers in a new era.
Immuno-oncology bladder drug wins approval
Soon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.
$96.5 Million Generic Payout Latest Trouble for Mylan
A $96.5 million settlement is the latest in a series of pricing and competition issues Mylan has faced in the past year.
How New Biosimilars Will Impact the Market
More biosimilars are coming onto the market , including competitors for Remicade and Neulasta.

Poll

View Results